Frequency and spectrum of atypical BCR-ABL1 transcripts in chronic myeloid leukemia von Kearney, L, Crampe, M, Langabeer, S E

Volltext

The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT von Langabeer, S E, McCarron, S L, Haslam, K, O'Donovan, M T, Conneally, E

Volltext

Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia von Langabeer, S E, Haslam, K, Crampe, M, MacDonagh, B, McHugh, J

Volltext

Screening for CRLF2 overexpression in adult acute lymphoblastic leukemia von Haslam, K., Kelly, J., Morris, T., Connaghan, G., Gilligan, O., Browne, P., Langabeer, S.E.

Volltext

Screening for CRLF2 overexpression in adult acute lymphoblastic leukemia: LETTER TO THE EDITOR von Haslam, K., Kelly, J., Morris, T., Connaghan, G., Gilligan, O., Browne, P., Langabeer, S.E.

Volltext

Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia von LANGABEER, S. E, GALE, R. E, HARVEY, R. C, COOK, R. W, MACKINNON, S, LINCH, D. C

Volltext

Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minim... von Kottaridis, P.D, Gale, R.E, Langabeer, S.E, Frew, M.E, Bowen, D.T, Linch, D.C

Volltext bestellen

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the... von Kottaridis, P.D, Gale, R.E, Frew, M.E, Harrison, G, Langabeer, S.E, Belton, A.A, Walker, H, Wheatley, K, Bowen, D.T, Burnett, A.K, Goldstone, A.H, Linch, D.C

Volltext bestellen